BRYAN KAPLAN: Open Payments
NPI 1841911310 · INDEPENDENCE, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$128 in 7 payments from 5 companies in 2025. Trend: 2023 $382 · 2024 $372 · 2025 $128
Food & beverage: $128
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $49 |
| E.R. Squibb & Sons, L.L.C. | 1 | $26 |
| ABBVIE INC. | 1 | $23 |
| Novartis Pharmaceuticals Corporation | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: Wegovy, ELIQUIS, VRAYLAR, Rybelsus, LEQVIO, FARXIGA.
Industry payments across MO — which companies pay providers there.
